Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559–64.
CAS PubMed Article Google Scholar
Qian C-N, Mei Y, Zhang J. Cancer metastasis: issues and challenges. Chin J Cancer. 2017;36:1–4.
Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X. Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol Ther. 2018;19:858–68.
CAS PubMed PubMed Central Article Google Scholar
Scully OJ, Bay B-H, Yip G, Yu Y. Breast cancer metastasis. Cancer Genomics Proteom. 2012;9:311–20.
Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2006;24:5652–7.
Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008;113:2638–45.
Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol: Off J Am Soc Clin Oncol. 2008;26:2373–8.
Ye X, Brabletz T, Kang Y, Longmore GD, Nieto MA, Stanger BZ, et al. Upholding a role for EMT in breast cancer metastasis. Nature. 2017;547:E1–E3.
CAS PubMed PubMed Central Article Google Scholar
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.
CAS PubMed PubMed Central Article Google Scholar
Ci Y, Zhang Y, Liu Y, Lu S, Cao J, Li H, et al. Myricetin suppresses breast cancer metastasis through down‐regulating the activity of matrix metalloproteinase (MMP)‐2/9. Phytother Res. 2018;32:1373–81.
CAS PubMed Article Google Scholar
Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, et al. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011;102:815–27.
CAS PubMed Article Google Scholar
Wu WS, You RI, Cheng CC, Lee MC, Lin TY, Hu CT. Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1. Sci Rep. 2017;7:17753.
PubMed PubMed Central Article CAS Google Scholar
Emmerson PJ, Duffin KL, Chintharlapalli S, Wu X. GDF15 and growth control. Front Physiol. 2018;9:1712.
PubMed PubMed Central Article Google Scholar
Wischhusen J, Melero I, Fridman WH. Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020;11:951.
CAS PubMed PubMed Central Article Google Scholar
Yang L, Chang C-C, Sun Z, Madsen D, Zhu H, Padkjær SB, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23:1158–66.
CAS PubMed Article Google Scholar
Fang L, Li F, Gu C. GDF-15: a multifunctional modulator and potential therapeutic target in cancer. Curr Pharm Des. 2019;25:654–62.
CAS PubMed Article Google Scholar
Lu X, He X, Su J, Wang J, Liu X, Xu K, et al. EZH2-mediated epigenetic suppression of GDF15 predicts a poor prognosis and regulates cell proliferation in non-small-cell lung cancer. Mol Ther Nucleic Acids. 2018;12:309–18.
CAS PubMed PubMed Central Article Google Scholar
Zhang Y, Wang X, Zhang M, Zhang Z, Jiang L, Li L. GDF15 promotes epithelial-to-mesenchymal transition in colorectal [corrected]. Artif Cells Nanomed Biotechnol. 2018;46:652–8.
CAS PubMed Article Google Scholar
Talreja O, Cassagnol M. Diltiazem. Treasure Island (FL): StatPearls Publishing: (2021). https://www.ncbi.nlm.nih.gov/books/NBK532937/.
Wong B-S, Chiu L-Y, Tu D-G, Sheu G-T, Chan T-T. Anticancer effects of antihypertensive L-type calcium channel blockers on chemoresistant lung cancer cells via autophagy and apoptosis. Cancer Manag Res. 2020;12:1913.
CAS PubMed PubMed Central Article Google Scholar
Alqudah MA, Alrababah BA, Mhaidat NM. Amlodipine inhibits cell proliferation and induces cell cycle arrest in colorectal cancer cells. Jordan J Pharm Sci. 2017;110:1–8.
Al-Malky HS, Osman A-MM, Damanhouri ZA, Alkreathy HM, Al Aama JY, Ramadan WS, et al. Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals. Cancer Cell Int. 2019;19:1–10.
Chiu L-Y, Ko J-L, Lee Y-J, Yang T-Y, Tee Y-T, Sheu G-T. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. Toxicol Lett. 2010;192:408–18.
CAS PubMed Article Google Scholar
Jiang P, Enomoto A, Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. 2009;284:122–30.
CAS PubMed Article Google Scholar
Van Impe K, Bethuyne J, Cool S, Impens F, Ruano-Gallego D, De Wever O, et al. A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis. Breast Cancer Res. 2013;15:1–15.
Patergnani S, Danese A, Bouhamida E, Aguiari G, Previati M, Pinton P, et al. Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer. Int J Mol Sci. 2020;21:8323.
CAS PubMed Central Article Google Scholar
Hardell L, Axelson O, Fredrikson M. Antihypertensive drugs and risk of malignant diseases. Lancet. 1996;348:542.
CAS PubMed Article Google Scholar
Kaplan NM. Do calcium antagonists cause cancer? Lancet. 1996;348:541–2.
CAS PubMed Article Google Scholar
Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 1996;348:493–7.
CAS PubMed Article Google Scholar
Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 1996;9:695–9.
CAS PubMed Article Google Scholar
Durham AC, Walton JM. Calcium ions and the control of proliferation in normal and cancer cells. Biosci Rep. 1982;2:15–30.
CAS PubMed Article Google Scholar
Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995;9:219–28.
CAS PubMed Article Google Scholar
Horton R. Do calcium antagonists cause cancer? Lancet. 1996;348:49.
Grimaldi-Bensouda L, Klungel O, Kurz X, de Groot MC, Maciel Afonso AS, de Bruin ML, et al. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 2016;6:e009147.
PubMed PubMed Central Article Google Scholar
Wilson LE, D’Aloisio AA, Sandler DP, Taylor JA. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women. Breast Cancer Res. 2016;18:61.
PubMed PubMed Central Article Google Scholar
Buchanan PJ, McCloskey KD. Ca V channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics. Eur Biophysics J. 2016;45:621–33.
Cui C, Merritt R, Fu L, Pan Z. Targeting calcium signaling in cancer therapy. Acta Pharmaceutica Sin B. 2017;7:3–17.
Diezel W, Gruner S, Diaz LA, Anhalt GJ. Inhibition of cutaneous contact hypersensitivity by calcium transport inhibitors lanthanum and diltiazem. J Investigative Dermatol. 1989;93:322–6.
Donovan M, Cotter T. Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development. Cell Death Differ. 2002;9:1220–31.
CAS PubMed Article Google Scholar
Westermann D, Knollmann BC, Steendijk P, Rutschow S, Riad A, Pauschinger M, et al. Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy. Eur J Heart Fail. 2006;8:115–21.
CAS PubMed Article Google Scholar
Wang J, Peng Q, Lin Q, Childress C, Carey D, Yang W. Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition. J Biol Chem. 2010;285:12279–88.
CAS PubMed PubMed Central Article Google Scholar
Mukherjee R, Das A, Chakrabarti S, Chakrabarti O. Calcium dependent regulation of protein ubiquitination - Interplay between E3 ligases and calcium binding proteins. Biochimica et Biophysica Acta Mol Cell Res. 2017;1864:1227–35.
留言 (0)